Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Key Pharma Players Changing The Dynamics Of Sch...

Schizophrenia is over a hundred years old term; and ever since it has kept the scientific communities scratching their head. Obvious psychotic symptoms, other neurodegenerative mimics, underdiagnos...

Oct 09, 2020

Osteosarcoma Market | Osteosarcoma key companies
Key Companies To Keep an Eye on for Pipeline Therapies in Osteosarcoma Market in the Next Decade

The current treatment approach for high-grade Osteosarcoma is conventional surgical resection of the primary tumor, along with systemic chemotherapies and radiation therapies in case of metastases and recurrence. Despite the rarity of Osteosarcoma, cancer poses a major global health burden with a global incidence r...

Find More
Osteosarcoma treatment market | Osteosarcoma unmet needs
Pitfalls of Current Osteosarcoma Treatment Approaches

Osteosarcomas are rare, yet are the leading cause of deaths due to cancer in the pediatric population. It is a high-grade malignancy of mesenchymal origins. They are the most frequent forms of primary bone tumors and account for approximately 20% of all the bone tumors. With the incident population of less than 250...

Find More
medical-marijuana-clinical-trials
Conditions Medical Marijuana is Anticipated to be Prescribed in the Offing

Marijuana also referred to as cannabis, is always in debate for its benefits and detriments. In some countries, it is legal while in some countries it is considered as a recreational and harmful product, and its cultivation, trafficking, possession, and ingesting can lead to a fine or even imprisonment. However, al...

Find More

More Views & Analysis

COVID-19 Vaccine News-Inovio, AZ, J&J; Latest HES Rare Disease News
Inovio’s COVID vaccine trial On-hold; Appeal to Pfizer; XtalPi’s massive raise; GSK Nucala’s HES approval; J&J’s COVID vaccine

Inovio’s shares plunge after FDA holds-off its COVID-19 vaccine Phase II/III trial  Inovio’s COVID-19 vaccine, INO-4800, Phase II/III clinical trials’ have been put under partial hold after the USFDA raised questions. The firm mentioned the reason behind the halt of the trials is not due to adverse events i...

Find More

Glioblastoma-Multiforme-Market-Analysis-and-Pipeline-Insights
Glioblastoma Multiforme Market: Emerging Pipeline Therapies To Keep A Keen Eye On

The present Glioblastoma multiforme (GBM) market has several unmet needs. Poor prognosis, 10-15 months median survival rate, no curative treatment to the patients, limited treatment options, drug resistance, incapability of therapies to cross BBB (blood-brain-barrier), intratumor heterogeneity, and a high mortality...

Find More

Glioblastoma multiforme Treatment Market | GBM Treatment Market
Huge Unmet Needs in the Glioblastoma Multiforme Treatment Market Driving the Market Size Growth

Headaches. Blurred vision. Nausea. No or poor appetite. Behavioral changes. Trouble thinking. These are some common problems people experience in their daily lives; however, are easy to write off as momentary or sideline in the name of stress. Yet, these constitute some of the common early symptoms of Glioblastoma ...

Find More

Peripheral nerve injury market | PNI Market
Roadblocks In The Peripheral Nerve Injury Market Require A Multi-faceted Approach

Each year, approximately 1.35 million people die due to vehicular or road accidents. Road crashes are also the most common cause of peripheral nerve injury (PNI), affecting the brachial BP or the radial, fibular, or sciatic nerves, typically in young motorcycle riders. These fragile and delicate nerves can be easil...

Find More

Cervical Cancer Market | Cervical Cancer Pipeline
Cervical Cancer Market Has A Lot Going On Under The Hood

Cervical cancer is the fourth most common type of cancer and the fourth leading cause of death in women. The year 2018 reported approximately 570 000 cases of cervical cancer. And 311 000 women died from the tumor. According to the Cervical Cancer Market report by DelveInsight, cervical cancer incidence by 2020...

Find More

Cervical Cancer Screening | HPV Vaccine
Preventing Cervical Cancer Through Screening And HPV Vaccines

Cervical cancer is the fourth most commonly diagnosed cancer in women after breast cancer, colorectal cancer, and lung cancer.  Although Cervical cancer rates vary geographically, several studies have demonstrated an incommensurably high prevalence in developing nations. Of all the cases recorded in 2018 world...

Find More

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Find More

Atrial fibrillation market is brimming with novel therapies in different stages of clinical developm.....

Find More

Soft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....

Find More

Celiac disease is an autoimmune disorder against the gluten consumed that creates toxins, thereby, d.....

Find More

Gastroesophageal Reflux Disease (GERD, also known as chronic acid reflux) is a digestive disorder in.....

Find More

Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access system.....

Find More